-
Mashup Score: 4Inside the nascent industry of AI-designed drugs - 11 month(s) ago
Artificial intelligence tools are beginning to upend the drug discovery pipeline, with several new compounds entering clinical trials.
Source: www.nature.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0FDA and NIH/NCI Center for Cancer Research - 12 month(s) ago
FDA and NIH/NCI Center for Cancer Research: Advancing Drug Development in Myelodysplastic Syndromes. Virtual 2-day free public workshop.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Today, May 16, at 12:30 pm ET, hear from @FDAOncology @NCIResearchCtr experts, academia, pharma, and patient advocates on efforts to advance #drugdevelopment in #myelodysplastic syndromes. @KellyNorsworth2 @StevenPavletic Info/Register: https://t.co/GEUdT0quqC https://t.co/JKSDzcay0z
-
-
Mashup Score: 1FDA and NIH/NCI Center for Cancer Research - 12 month(s) ago
FDA and NIH/NCI Center for Cancer Research: Advancing Drug Development in Myelodysplastic Syndromes. Virtual 2-day free public workshop.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
May 16-17: @FDAOncology @NCIResearchCtr Public Workshop to Advance #DrugDevelopment in #MDS. 2 days w/experts from govt, academia, pharma, patient advocates discussing optimal #clinicaltrials design. #mdssm @KellyNorsworth2 @StevenPavletic Info/Register: https://t.co/GEUdT0quqC https://t.co/EdGZeAyBsZ
-
-
Mashup Score: 0FDA and NIH/NCI Center for Cancer Research - 12 month(s) ago
FDA and NIH/NCI Center for Cancer Research: Advancing Drug Development in Myelodysplastic Syndromes. Virtual 2-day free public workshop.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
May 16-17: @FDAOncology @NCIResearchCtr Public Workshop to Advance #DrugDevelopment in #MDS. 2 days w/experts from govt, academia, pharma, patient advocates discussing optimal #clinicaltrials design. #mdssm @KellyNorsworth2 @StevenPavletic Info/Register: https://t.co/GEUdT0quqC https://t.co/eveWBf8rr4
-
-
Mashup Score: 25Take the Course - Progress for Patients - 12 month(s) ago
Through the ProgressForPatients.org Advocacy Education Program, we’ll educate and empower you to make the connections necessary to engage with the drug development process and communicate your experience.
Source: Progress for PatientsCategories: Hem/Oncs, Latest HeadlinesTweet-
Are you interested in becoming involved in patient #advocacy? Here’s a free 90 min course: https://t.co/8fs8Gn5x6p. #drugdevelopment #clinicaltrials #MedTwitter @CancerResrch
-
RT @tmprowell: Are you interested in becoming involved in patient #advocacy? Here’s a free 90 min course: https://t.co/8fs8Gn5x6p. #drugde…
-
-
Mashup Score: 4FDA and NIH/NCI Center for Cancer Research - 1 year(s) ago
FDA and NIH/NCI Center for Cancer Research: Advancing Drug Development in Myelodysplastic Syndromes. Virtual 2-day free public workshop.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
May 16-17: @FDAOncology @NCIResearchCtr Public Workshop to Advance #DrugDevelopment in #MDS. 2 days w/experts from govt, academia, pharma, patient advocates discussing optimal #clinicaltrials design. #mdssm @KellyNorsworth2 @StevenPavletic Info/Register: https://t.co/GEUdT0quqC https://t.co/vMJi3k133t
-
-
Mashup Score: 1FDA and NIH/NCI Center for Cancer Research - 1 year(s) ago
FDA and NIH/NCI Center for Cancer Research: Advancing Drug Development in Myelodysplastic Syndromes. Virtual 2-day free public workshop.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
May 16-17: @FDAOncology @NCIResearchCtr Public Workshop to Advance #DrugDevelopment in #MDS. 2 days w/experts from govt, academia, pharma, patient advocates discussing optimal #clinicaltrials design. #mdssm @KellyNorsworth2 @StevenPavletic Info/Register: https://t.co/GEUdT0quqC https://t.co/FSuxTCGCBX
-
-
Mashup Score: 1FDA and NIH/NCI Center for Cancer Research - 1 year(s) ago
FDA and NIH/NCI Center for Cancer Research: Advancing Drug Development in Myelodysplastic Syndromes. Virtual 2-day free public workshop.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
May 15-16: @FDAOncology @NCIResearchCtr Public Workshop to Advance #DrugDevelopment in #MDS. 2 days w/experts from govt, academia, pharma, patient advocates discussing optimal #clinicaltrials design. #mdssm @KellyNorsworth2 @StevenPavletic Info/Register: https://t.co/GEUdT0quqC https://t.co/IwktnQ28Pc
-
-
Mashup Score: 0
Fundings Orbital Therapeutics, a South San Francisco-based startup established just a year ago, has secured $270 million in Series A funding. This comes as interest grows in startups that leverage cutting-edge RNA technologies to develop pharmaceuticals and vaccines. ARCH Venture Partners took the lead in this investment round. Vedanta Biosciences,…
Source: www.linkedin.comCategories: Future of Medicine, Latest HeadlinesTweet-
Start your week with the latest #healthcare fundings - Orbital Therapeutics, Evommune, and more. #digitalhealth #drugdiscovery #drugdevelopment https://t.co/YwnTWq19EZ https://t.co/mlN3ap7ku0
-
-
Mashup Score: 2Webinar Registration - Zoom - 1 year(s) ago
Your registration for the FDA’s Advancing Drug Development in Myelodysplastic Syndromes (MDS) Workshop on May 16 and 17, 2023, is confirmed upon clicking the “Register” button. Once registered, you will be able to add a calendar appointment from the registration confirmation page.If you have questions, please contact project managers:laura.wisch@fda.hhs.gov or erin.purcell@fda.hhs.govReminder:…
Source: fda.zoomgov.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Registration open! @FDAOncology @NCIResearchCtr Public Workshop to Advance #DrugDevelopment in #MDS. 2 days w/experts from govt, academia, pharma, pt advocates discussing optimal #clinicaltrials design. #mdssm @KellyNorsworth2 @StevenPavletic Register: https://t.co/MAaxE8BAzi https://t.co/9TiiPZ60zL
-
Inside the nascent industry of AI-designed drugs https://t.co/SBCjTMbDaR #drugdevelopment #AI #digitalhealth #pharma #biotech #medicine https://t.co/56obyL1fGC